Metropolitan Life Insurance Company (MetLife)’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-331
| Closed | -$14.8K | – | 1219 |
|
|
2024
Q1 | $14.8K | Buy |
331
+14
| +4% | +$624 | ﹤0.01% | 1995 |
|
|
2023
Q4 | $12.3K | Sell |
317
-175
| -36% | -$6.79K | ﹤0.01% | 2111 |
|
|
2023
Q3 | $14.5K | Hold |
492
| – | – | ﹤0.01% | 2044 |
|
|
2023
Q2 | $31.3K | Hold |
492
| – | – | ﹤0.01% | 1693 |
|
|
2023
Q1 | $23.2K | Sell |
492
-45
| -8% | -$2.13K | ﹤0.01% | 1807 |
|
|
2022
Q4 | $37.3K | Hold |
537
| – | – | ﹤0.01% | 1651 |
|
|
2022
Q3 | $78.7K | Hold |
537
| – | – | ﹤0.01% | 1165 |
|
|
2022
Q2 | $70K | Buy |
537
+42
| +8% | +$5.48K | ﹤0.01% | 1290 |
|
|
2022
Q1 | $50K | Buy |
+495
| New | +$50K | ﹤0.01% | 1590 |
|
|
2021
Q4 | – | Sell |
-390
| Closed | -$116K | – | 2811 |
|
|
2021
Q3 | $116K | Buy |
+390
| New | +$116K | ﹤0.01% | 2443 |
|